Osteoporosis, bone & mineral

Temporal Variation of Biochemical Markers and Adenoma Predictors in Normocalcemic Primary Hyperparathyroidism: A Multicenter Retrospective Analysis

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

The large scale of our patient cohort reinforces the robustness of our statistical analyses and provides comprehensive insight into the dynamic nature of nPHPT. Our findings demonstrate that, even in normocalcemic patients, higher PTH levels and relatively higher calcium levels within the normal range are important indicators of parathyroid adenoma. Integrating serial biochemical measurements with targeted imaging can facilitate earlier diagnosis, potentially preventing future complications and informing more tailored management strategies.

Study context

Population
Normocalcemic patients diagnosed with primary hyperparathyroidism (normocalcemic primary hyperparathyroidism (nPHPT): persistently elevated parathyroid hormone (PTH) with normal serum calcium after excluding secondary causes such as vitamin D deficiency and renal impairment)
Participants
474 patients
Outcome
Temporal changes in biochemical markers, predictors of adenoma localisation and diagnostic accuracy
Methodological detailsmulticentre, Biochemical markers measured at three time points; imaging by US, sestamibi scintigraphy and CT
  • Multicentre
  • Biochemical markers measured at three time points; imaging by US, sestamibi scintigraphy and CT

Main finding

As reported in the abstract

PTH had the highest diagnostic accuracy, AUC

0.91

95% CI 0.84–0.95p < 0.001

Observational data: associations, not effects.

Original publication

Temporal Variation of Biochemical Markers and Adenoma Predictors in Normocalcemic Primary Hyperparathyroidism: A Multicenter Retrospective Analysis. Clin Endocrinol (Oxf). Published 2 September 2025. doi:10.1111/cen.70024

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.